0001415889-18-000910.txt : 20180608 0001415889-18-000910.hdr.sgml : 20180608 20180608170532 ACCESSION NUMBER: 0001415889-18-000910 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180606 FILED AS OF DATE: 20180608 DATE AS OF CHANGE: 20180608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brege Laura CENTRAL INDEX KEY: 0001365619 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 18890241 MAIL ADDRESS: STREET 1: C/O ONYX PHARMACEUTICALS, INC. STREET 2: 2100 POWELL STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 form4-06082018_020616.xml X0306 4 2018-06-06 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001365619 Brege Laura 3611 VALLEY CENTRE DRIVE, SUITE 300 SAN DIEGO CA 92130 true false false false Stock option (right to buy) 17.52 2018-06-06 4 A 0 15000 0 A 2028-06-05 Common Stock 15000 15000 D 25% of the shares subject to the Stock Option vest and become exercisable at the end of each 3-month period following the date of grant. /s/ Glenn F. Baity, Attorney-in-Fact 2018-06-08